• Sensex74068.451372.06(1.88%)
  • Nifty22912.4399.75(1.77%)
  • USDINR93.88-0.02(-0.02%)
Online tarding Partner With Us
BSE Prices delayed by 5 minutes ! Prices as on   Mar 24, 2026   ABB India 6157.45 [ 1.96% ]ACC 1334.1 [ 0.29% ]Ambuja Cements 407.55 [ 3.07% ]Asian Paints 2216.8 [ 4.54% ]Axis Bank 1192 [ 1.82% ]Bajaj Auto 8899.1 [ 1.38% ]Bank of Baroda 270.75 [ 1.86% ]Bharti Airtel 1803.6 [ 0.41% ]Bharat Heavy 258.1 [ 2.12% ]Bharat Petroleum 282.25 [ 3.96% ]Britannia Industries 5511.5 [ 0.37% ]Cipla 1219.3 [ -0.28% ]Coal India 441.9 [ -2.96% ]Colgate Palm 1877.65 [ 1.53% ]Dabur India 421.5 [ 0.99% ]DLF 521.2 [ 1.28% ]Dr. Reddy's Lab. 1259.6 [ 0.56% ]GAIL (India) 137.75 [ 1.77% ]Grasim Industries 2545.85 [ 0.55% ]HCL Technologies 1373.35 [ 1.10% ]HDFC Bank 765.15 [ 2.88% ]Hero MotoCorp 5252 [ 3.66% ]Hindustan Unilever 2084.7 [ 1.49% ]Hindalco Industries 854.55 [ 1.82% ]ICICI Bank 1251.7 [ 2.38% ]Indian Hotels Co. 604.1 [ 3.71% ]IndusInd Bank 798.05 [ 2.58% ]Infosys 1278.2 [ 1.60% ]ITC 291.2 [ 0.28% ]Jindal Steel 1120.1 [ 1.28% ]Kotak Mahindra Bank 367.15 [ 3.03% ]L&T 3515.35 [ 5.19% ]Lupin 2331.75 [ 1.50% ]Mahi. & Mahi 3032.55 [ 2.57% ]Maruti Suzuki India 12467.5 [ 0.92% ]MTNL 23.91 [ 2.93% ]Nestle India 1182.85 [ 1.40% ]NIIT 54.73 [ 0.57% ]NMDC 76.7 [ 2.17% ]NTPC 375.45 [ 0.78% ]ONGC 268.1 [ 1.04% ]Punj. NationlBak 107.25 [ 1.71% ]Power Grid Corpn. 299.2 [ -0.81% ]Reliance Industries 1411.45 [ 0.30% ]SBI 1030.8 [ -0.09% ]Vedanta 651.75 [ 0.93% ]Shipping Corpn. 230.15 [ 4.95% ]Sun Pharmaceutical 1752.8 [ -0.20% ]Tata Chemicals 609.05 [ 0.09% ]Tata Consumer 1053.2 [ 2.91% ]Tata Motors Passenge 311.25 [ 2.00% ]Tata Steel 190.9 [ 1.95% ]Tata Power Co. 384.75 [ -0.57% ]Tata Consult. Serv. 2398.8 [ 0.67% ]Tech Mahindra 1432.9 [ 3.57% ]UltraTech Cement 10760.85 [ 3.87% ]United Spirits 1327.6 [ 4.12% ]Wipro 188.75 [ 0.67% ]Zee Entertainment 71.52 [ 4.45% ]
BSE

MARKETS

News Details

( As on 17/03/2026 15:27)

Lupin, Zydus partner to co-market semaglutide injection in India

Lupin Limited has entered into a licensing and supply agreement with Zydus Lifesciences Limited to co-market an innovative semaglutide injection in India, aimed at expanding access to advanced therapies for diabetes and weight management.

Under the agreement, Lupin will have semi-exclusive rights to market the product in India under the brands Semanext and Livarise, while Zydus will continue to sell it under its existing brands. The partnership combines Lupin’s strong domestic reach with Zydus’ development capabilities.

As part of the deal, Lupin will pay upfront licensing fees along with milestone-based payments tied to predefined targets.

Semaglutide is used for the treatment of type 2 diabetes as well as for chronic weight management in adults, alongside diet and exercise. The product features a patient-friendly reusable pen device designed to improve ease of use and adherence.

The companies said the collaboration aims to enhance access to innovative treatment options for cardio-metabolic diseases and address growing patient needs across India.